Retinoids and Drugs of Abuse: Implications for Neurological Disease Risk in Human Immunodeficiency Virus Type 1 Infection

Clinical Infectious Diseases

Volumn 37, Issue 12 SUPPL. 5, 2003, Pages

  Royal III, W ^a   Vlahov, D ^b,d   Lyles, C ^d   Gajewski, C D ^c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ILLICIT DRUG; MORPHINE SULFATE; PREALBUMIN; RETINOIC ACID; RETINOID; RETINOL; RETINOL BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INJECTION DRUG USER; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RETINOL DEFICIENCY; RISK; VITAMIN METABOLISM;

AIDS DEMENTIA COMPLEX; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; MORPHINE; NERVOUS SYSTEM DISEASES; PREALBUMIN; RETINOIDS; RETINOL-BINDING PROTEINS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 0347479187     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377554     Document Type: Article

References (45)

1. Simpson DM, Berger JR. Neurologic manifestations of HIV infection. Med Clin North Am 1996; 80:1363-94.
2. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 19:525-35.
3. Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332:934-40.
4. McManus CM, Brosnan CF, Berman JW. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J Immunol 1998; 160:1449-55.
5. Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998; 95:3117-21.
6. Karter DL, Karter AJ, Yarrish R, et al. Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:199-203.
7. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993; 153:2149-54.
8. Semba RD, Muhilal, Ward BJ, et al. Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet 1993; 341:5-8.
9. + cells in human blood. Immunol Lett 1985; 9: 221-4.
10. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS 1995; 9:1051-6.
11. Centers for Disease Control and Prevention. HIV/AIDS Surveill Rep 2000; 12:37. Available at. http://www.cdc.gov/hiv/stats/hasr1202.pdf. Accessed 14 November 2003.
12. Welters ID, Menzebach A, Goumon Y, et al. Morphine inhibits NF-KappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 2000; 92:1677-84.
13. Nair MPN, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC. Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol 1997; 4:127-32.
14. Peterson PK, Gekker G, Hu S, et al. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol 1994; 50:167-75.
15. Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour HH Jr. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990; 4:869-73.
16. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998; 121:2043-52.
17. Selnes OA, Galai N, McArthur JC, et al. HIV infection and cognition in intravenous drug users: long-term follow-up. Neurology 1997; 48: 223-30.
18. Royal W 3rd, Updike M, Selnes OA, et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991; 41:1905-10.
19. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109:75-100.
20. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 1979; 32:2143-9.
21. Cantorna MT, Nashold FE, Hayes CE. In vitamin A deficiency multiple mechanisms establish a regulatory t helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 1994; 152:1515-22.
22. Sommer A, Katz J, Tarwotjo I. Increased risk of respiratory disease and diarrhea in children with preexisting mild vitamin A deficiency. Am J Clin Nutr 1984; 40:1090-5.
23. Bloem MW, Wedel M, Egger RJ, et al. Mild vitamin A deficiency and risk of respiratory tract diseases and diarrhea in preschool and school children in northeastern Thailand. Am J Epidemiol 1990; 131:322-39.
24. Royal W III, Semba RD, Park SR. Measurement of cerebrospinal fluid retinol in subjects with HIV-1 infection. Immunol Infect Dis 1996; 6:99-103.
25. Chlebowski RT, Grosvenor MB, Bernhard NH, Morales LS, Bulcavage LM. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989; 84:1288-93.
26. Smit E, Graham NMH, Tang A, Flynn C, Solomon C, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996; 12:496-501.
27. Vlahov D, Anthony JC, Munoz A. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users, description of methods. In: Hartsock PI, Genser SG, eds. Longitudinal studies of HIV infection in intravenous drug users. Rockville, MD: National Institute on Drug Abuse, 1991:75-100.
28. Nerad JL, Gorbach SL. Nutritional aspects of HIV infection. Infect Dis Clin North Am 1994; 8:499-515.
29. Kennedy CM, Kuhn L, Stein Z. Vitamin A and HIV infection: disease progression, mortality, and transmission. Nutr Rev 2000; 58:291-303.
30. Herbert J, Wilcox JN, Pham KTC, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 1986; 36: 900-11.
31. Duan W, Schreiber G. Expression of retinol-binding protein mRNA in mammalian choroid plexus. Comp Biochem Physiol B 1992; 101: 399-406.
32. Aleshire SL, Bradley CA, Richardson LD, Parl FF. Localization of human prealbumin in choroid plexus epithelium. J Histochem Cytochem 1983; 31:608-12.
33. Cavanna A, Giovine G, Tappero R, Torchio M, Avagnina P, Molino G. Diagnostic value of prealbumin and retinol-binding protein in acute and chronic liver diseases. Ric Clin Lab 1985; 15:71-7.
34. Ingenbleek Y, de Visscher M, De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet 1972; 2:106-8.
35. Rosales FJ, Riter SJ, Zolfaghari R, Smith JE, Ross AC. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. J Lipid Res 1996; 37:962-71.
36. Stephensen CB, Alvarex JO, Kohatsu J, Hardmeier R, Kennedy JI Jr, Gammon RB Jr. Vitamin A is excreted in the urine during acute infection. Am J Clin Nutr 1994; 60:388-92.
37. Filteau SM. Vitamin A and the acute-phase response [editorial]. Nutrition 1999; 15:326-8.
38. Soprano DR, Blaner WS. Plasma retinol-binding protein. In: Sporn MB, Roberts AB, Goodman DS, eds. The retinoids. 2nd ed. New York: Raven Press, 1994:275.
39. Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles CM, Astemborski J. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS Studies. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:275-82.
40. Galai N, Vlahov D, Margolick JB, Chen K, Graham NM, Munoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:66-74.
41. Alcabes P, Munoz A, Vlahov D, Friedland G. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol 1994; 4:17-26.
42. Chaisson RE, Taylor E, Margolick JB, et al. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr 1992; 5:456-60.
43. Lyles CM, Graham NM, Astemborski J, et al. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. Eur J Epidemiol 1999; 15:99-108.
44. Donahoe RM, Byrd LD, McClure HM, et al. Consequences of opiate-dependency in a monkey model of AIDS. Adv Exp Med Biol 1993; 335:21-8.
45. Donahoe RM, Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 1998; 83:77-87.